New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells
October 13, 2021
Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ) resistance in a subset of MGMT-negative and MMR-proficient cancer cell lines. continue reading »